| #42 |
James Dodge |
Genzyme |
1 |
| #42 |
Jian Yin |
Az Electronic Materials (Luxembourg) S.A.R.L. |
1 |
| #42 |
Paul S. Westbrook |
Ofs Fitel |
1 |
| #42 |
Brian Swanson |
Regeneron Pharmaceuticals |
1 |
| #42 |
Praveen Venkataramu |
Cellco Partnership |
1 |
| #42 |
Yih-Farn Chen |
AT&T |
1 |
| #42 |
Ji Wang |
Guandong Ocean University |
1 |
| #42 |
Michael L. Steigerwald |
AT&T |
1 |
| #42 |
M. Scott Corson |
Qualcomm |
1 |
| #42 |
Boris A. Kurchuk |
AT&T |
1 |
| #42 |
Satish Pejaver |
Innopharmax |
1 |
| #42 |
Tabassumul Haque |
ExxonMobil |
1 |
| #42 |
X. Kate Zhang |
Genzyme |
1 |
| #42 |
Gerald F. Cox |
Genzyme |
1 |
| #42 |
Baeksan Oh |
Samsung |
1 |
| #42 |
Ajai Pal |
Anthrogenesis |
1 |
| #42 |
James Alaimo |
AT&T |
1 |
| #42 |
Kenneth Sultzbaugh |
Intermune |
1 |
| #42 |
Thomas A. Warren |
Verizon |
1 |
| #42 |
Francesca Lawson |
Sanofi-Aventis |
1 |
| #42 |
Xiaodan Wei |
Sanofi-Aventis |
1 |
| #42 |
Kirsten Bjegarde |
Sanofi |
1 |
| #42 |
Nevenka Golubovic-Liakopoulos |
Apogee Technology Consultants |
1 |
| #42 |
Irina Grigorian |
Hydromer |
1 |
| #42 |
John Norman Mailhot |
AT&T |
1 |
| #42 |
Lisa Sawin |
Ericsson |
1 |
| #42 |
Yi Yang |
Au Optronics |
1 |
| #42 |
Mahsa Rohani |
Genzyme |
1 |
| #42 |
James M. Balkovec |
Merck |
1 |
| #42 |
John F. Brody |
ExxonMobil |
1 |
| #42 |
Christina Odorisio |
Corn Products Development |
1 |
| #42 |
David Vallone |
Goldman Sachs |
1 |
| #42 |
Girish Malangi |
Gartner |
1 |
| #42 |
Binoy K. Bordoloi |
Johnson & Johnson |
1 |
| #42 |
Jonathan C. Gray |
UPS |
1 |